Herbert Virgin Vir Biotechnology, Inc. (VIR) insider trading activity

Herbert Virgin is EVP, Research & CSO of Vir Biotechnology, Inc.. Currently has a direct ownership of 262,500 shares of VIR, which is worth approximately $1.76 Million. The most recent transaction as insider was on Oct 19, 2021, when has been sold 1,375 shares (Common Stock) at a price of $1.53 per share, resulting in proceeds of $2,104. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 263K

0% 3M change

0% 12M change

Total Value Held $1.76 Million

Herbert Virgin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 19 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Oct 05 2021	SELL Open market or private sale	$46,406 $33.75 p/Share	1,375 Reduced 1.26%	107,700 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.24%	109,075 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$12,240 $1.53 p/Share	8,000 Added 6.91%	107,700 Common Stock
Sep 21 2021	SELL Open market or private sale	$206,250 $50.0 p/Share	4,125 Reduced 3.97%	99,700 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$6,311 $1.53 p/Share	4,125 Added 3.82%	103,825 Common Stock
Sep 07 2021	SELL Open market or private sale	$204,188 $49.5 p/Share	4,125 Reduced 3.97%	99,700 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$6,311 $1.53 p/Share	4,125 Added 3.82%	103,825 Common Stock
Aug 25 2021	SELL Open market or private sale	$137,500 $50.0 p/Share	2,750 Reduced 2.68%	99,700 Common Stock
Aug 25 2021	BUY Exercise of conversion of derivative security	$4,207 $1.53 p/Share	2,750 Added 2.61%	102,450 Common Stock
Aug 24 2021	SELL Open market or private sale	$66,000 $48.0 p/Share	1,375 Reduced 1.36%	99,700 Common Stock
Aug 24 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.34%	101,075 Common Stock
Aug 23 2021	SELL Open market or private sale	$687,500 $50.0 p/Share	13,750 Reduced 12.12%	99,700 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$21,037 $1.53 p/Share	13,750 Added 10.81%	113,450 Common Stock
Aug 10 2021	SELL Open market or private sale	$56,375 $41.0 p/Share	1,375 Reduced 1.36%	99,700 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.34%	101,075 Common Stock
Jul 27 2021	SELL Open market or private sale	$50,490 $36.72 p/Share	1,375 Reduced 1.36%	99,700 Common Stock
Jul 27 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.34%	101,075 Common Stock
Jul 13 2021	SELL Open market or private sale	$50,490 $36.72 p/Share	1,375 Reduced 1.36%	99,700 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.34%	101,075 Common Stock
Jun 29 2021	SELL Open market or private sale	$64,116 $46.63 p/Share	1,375 Reduced 1.36%	99,700 Common Stock
Jun 29 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.34%	101,075 Common Stock
Jun 23 2021	BUY Exercise of conversion of derivative security	$12,240 $1.53 p/Share	8,000 Added 7.43%	99,700 Common Stock
Jun 15 2021	SELL Open market or private sale	$62,274 $45.29 p/Share	1,375 Reduced 1.48%	91,700 Common Stock
Jun 15 2021	BUY Exercise of conversion of derivative security	$2,104 $1.53 p/Share	1,375 Added 1.46%	93,075 Common Stock

Herbert Virgin

EVP, Research & CSO

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Value

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR

Account